ArticleGynecologic oncology2025
Influence of residential segregation and health provider density on advanced stage endometrial cancer diagnoses.
Article in Gynecologic oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Endometrial cancer therapy in 2026.Current opinion in obstetrics & gynecology · 2026Review
- American Cancer Society's Report on the Status of Cancer Disparities in the United States, 2025.CA: a cancer journal for cliniciansArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
introductionThe influence of residential segregation and provider density on endometrial (EC) presentation is not fully known. Our objective was to determine associations between county-level obstetrics-gynecology provider density and residential segregation as measured by the Index of Concentration (ICE) at the Extremes on late-stage EC diagnoses in Florida.
methodsAll malignant EC cases were identified from 2001 to 2017 in the Florida Cancer Data System (FCDS). Using 5-year estimates from the 2013-2017 American Community Survey, five county-level ICE variables were calculated: economic (high vs low), race and/or ethnicity (non-Hispanic white [NHW] vs. non)-Hispanic Black [NHB] and NHW vs. Hispanic), and racialized economic segregation (low-income NHB vs. high-income NHW and low-income Hispanic vs. high-income NHW). County-level provider density was calculated. Multivariable-adjusted logistic regression models were specified to estimate the associations.
resultsThere were 44,678 EC cases with stage information. More NHB women (27.1 %) were diagnosed with aggressive EC histologies relative to NHW (16.4 %) and Hispanic women (15.5 %) (p < 0.001). NHB and Hispanic women had significantly greater odds of being diagnosed with later-stage EC compared to NHW women, regardless of residential segregation (OR: 1.46, 95 % CI: 1.36, 1.56 and OR: 1.09, 95 % CI: 1.01, 1.17, respectively). Women living in the most economically disadvantaged Hispanic segregated counties had greater odds of being diagnosed with later-stage EC compared to those living in more NHW segregated areas (OR: 1.16, 95 % CI: 1.00, 1.35). Provider density was not associated with later-stage diagnosis.
conclusionAdvanced stage EC at diagnosis seems to be largely independent of provider density and residential segregation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.